Holdings A/S Novo - Nov 4, 2021 Form 3 Insider Report for IO Biotech, Inc. (IOBT)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel of Novo Holdings A/S
Stock symbol
IOBT
Transactions as of
Nov 4, 2021
Transactions value $
$0
Form type
3
Date filed
11/4/2021, 05:15 PM
Previous filing
Oct 27, 2021
Next filing
Nov 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IOBT SERIES B CONVERTIBLE PREFERRED STOCK Nov 4, 2021 COMMON STOCK 2.01M Direct F1
holding IOBT SERIES C CONVERTIBLE PREFERRED STOCK Nov 4, 2021 COMMON STOCK 946K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of preferred stock convert to common stock based on a conversion ratio that takes into account interest that accrues since the date of issuance of such preferred stock and the price of the stock sold to the underwriters in the IPO.